title: The development of androgen-independent prostate cancer.
abstract: The normal prostate and early-stage prostate cancers depend on androgens for growth and survival, and androgen ablation therapy causes them to regress. Cancers that are not cured by surgery eventually become androgen independent, rendering anti-androgen therapy ineffective. But how does androgen independence arise? We predict that understanding the pathways that lead to the development of androgen-independent prostate cancer will pave the way to effective therapies for these, at present, untreatable cancers.
authors.affiliation: Department of Medicine, Stanford University School of Medicine, California 94305-5103, USA. feldman@cmgm.stanford.edu
authors.forename: B J
authors.initials: BJ
authors.lastname: Feldman
authors.forename: D
authors.initials: D
authors.lastname: Feldman
mesh_terms: D000728:Androgens / Q000032:analysis / Q000502:physiology*; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D008297:Male; D009154:Mutation; D011471:Prostatic Neoplasms / Q000209:etiology* / Q000628:therapy; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology; D011944:Receptors, Androgen / Q000235:genetics / Q000502:physiology
chemical_list: D000728:Androgens; D006133:Growth Substances; D011944:Receptors, Androgen; D020794:Receptor Protein-Tyrosine Kinases